Monatliche Archive: März 2020
Health authority responses to the COVID-19 impact on clinical research
The COVID-19 crisis places a huge burden on the healthcare systems of countries around the [...]
Mrz
Fifteen most-frequently asked questions on Clinical Evaluation for Europe
One of the significant changes in EU regulatory science for medical devices is the enhanced [...]
Mrz
Webinar: What you should know when designing a PMCF Plan for your Medical Device
According to the KPMG/RAPS survey results published in September 2019, 43% of Medical Device respondents [...]
Mrz
Meet and Greet with Wiebe Postma at the 4th Annual European Medical Device Investigator Initiated Study Meeting
January 29, 2020 – January 30, 2020 / Europe – Brussels, Belgium (Sheraton Brussels Airport Hotel, Belgium) [...]
Mrz
Monitoring in Medical Device studies: what is needed?
If you are a manufacturer who started a clinical trial, then you have the obligation [...]
Mrz
The research naïve study site – always a problem?
Your potential investigator / KOL is very enthusiastic to do your study but does not [...]
Mrz
Key Opinion leader engagement for your clinical investigation
What can KOLs add to your Clinical Investigation? Key opinion leaders (KOLs) are experts and [...]
Mrz